Isabelle Janoueix-Lerosey

10PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersMolecular targetsSolid tumoursCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 04, 2023
Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma.

Cécile Thirant, Agathe Peltier, Simon Durand

|Jan 05, 2023
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.

Elizabeth R Tucker, Irene Jiménez, Lindi Chen

|Sep 02, 2022
Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma.

Ana Costa, Cécile Thirant, Amira Kramdi

|Jul 02, 2021
Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT).

Margot Gautier, Cécile Thirant, Olivier Delattre

|Oct 25, 2019
Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade.

Tala Shekarian, Eva Sivado, Anne-Catherine Jallas

Pageof 2